UTEK Corporation Transfers A Worldwide License For A New Treatment Of Glaucoma To Advanced Refractive Technologies

TAMPA, Fla. & SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Aug. 11, 2006--UTEK Corporation (AMEX:UTK) (LSE-AIM:UTK), a specialty finance company focused on technology transfer, and Advanced Refractive Technologies, Inc. (OTCBB:ARFR), a medical device company focused on the development and marketing of innovative ophthalmic applications, announced today that Advanced Refractive Technologies has acquired Advanced Glaucoma Technologies, Inc., a subsidiary of UTEK Corporation, in a stock transaction.